Drug Allergy Market Size, Share, Development, Growth and Demand Forecast to 2023

marketresearchfuture

Drug Allergy is a standout amongst the most widely recognized sorts of hypersensitivities. It is the extreme touchiness of the safe framework to medication or drug. Any sorts of medications, for example, medicine, nonprescription or home grown can prompt Drug Allergy. Some basic manifestations of the medication sensitivities are hives, skin rash, tingling of the eyes or skin, swelling of the face, lips, or tongue, wheezing, and others. Treatment can ease and anticipate extreme responses.

Expanding mindfulness about different hypersensitivities, the presentation of the new treatment of items and rising interest from developing markets drives the development of the worldwide market. New research to forestall sedate hypersensitivities is another key driver for the market. The worldwide Drug Allergy Market is developing respectably and is required to proceed with its development over the figure time frame.

The global Drug Allergy Market is expected to grow at the CAGR of ~5.1% during the forecast period and is estimated to reach USD 4764.0 million by 2023.

Competitive Analysis:

Some of the key players in this market: AstraZeneca (UK), Bayer (US), Circassia (US), HAL Allergy Group (the Netherlands), Johnson & Johnson Services, Inc. (US), MAGNA Pharmaceuticals, Inc. (US), Stallergenes Greer (UK), and others.

Regional Analysis of the Global Drug Allergy Market:

The Americas dominate the global market for the drug allergy. The Americas mainly include North America and Latin America, out of which North America accounts for the majority of the market share of this region. The US is the top revenue generating market in North America and is one of the important markets for the global drug allergy treatment. Approximately 10% of the total US population have drug allergies. Latin America drug allergy market is also growing significantly and mainly includes Brazil, Argentina, and Chile. Europe is the second largest market in the globe owing to increasing cases of drug allergy.

Europe is mainly divided into Eastern Europe and Western Europe. More developed Western European countries like Germany, UK and France are dominating this market while East European region is also growing significantly. Increasing cases of drug allergies are one of the major factors for the growth of the Europe market.

Asia Pacific region is showing the fastest growth rate in the global drug allergy market due to some major factors such as increasing awareness about various drug allergies, availability of treatment products, and rapidly improving healthcare facilities. Japan is holding the major market share while China’s Drug Allergy Industry is expected to show the fastest growth in this region. Changing healthcare practices and increasing patient involvement play an important role in the growth of this market.

The Middle East & Africa is expected to experience a limited growth due to lack of awareness about diseases, traditional healthcare practices, etc. The Middle East region dominates the market due to some of the major factors, for instance, developed healthcare facilities and government support to improve public health.

Brief TOC

  1. Report Prologue
  2. Introduction
  3. Research Methodology
  4. Market Dynamics
  5. Market Factor Analysis
  6. Global Drug Allergy Market By Type
  7. Global Drug Allergy Market By Diagnosis
  8. Global Drug Allergy Market By Treatment
  9. Global Drug Allergy Market By End User
  10. Global Drug Allergy Market By Region
  11. Competitive Landscape
  12. Company Profile
  13. Conclusion
  14. Appendix

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact:

Akash Anand,

Market Research Future

+1 646 845 9312

Email: sales@marketresearchfuture.com

Shivkumar is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

Dental Infection Treatment Market Competitive landscape by 2023

Market Research Future adds new report of “Dental Infection Treatment Market Research Report – Global forecast till 2023” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Key players profiled in the report are Kerr Corporation, Patterson Dental Supply, Inc., Henry Schein, Inc., Pfizer Inc., Endo Pharmaceuticals, Johnson & Johnson, Taj Pharmaceuticals Limited, Septodont Healthcare India Pvt. Ltd., Bayer HealthCare, Ultradent Products Inc., Bristol-Myers Squibb, Daiichi Sankyo and others.

Market Segments:

The global dental infection treatment market is segmented on the basis of type, treatment and end users. Based on type, the market has been segmented as periapical abscess, periodontal abscess and others. Based on the treatment, the market has been segmented as drugs (antibiotics, pain killers, others), procedures (root canal, tooth fillings, tooth extraction, others). Based on the end users, the market has been segmented as dentistry clinics, hospitals and others.

Market Highlight:

Dental infection or tooth abscess is the infection of teeth, gums and associated tissue caused by a bacterial infection. The abscess can occur at different regions such as periapical abscess occurring at the tip of the root, and a periodontal abscess occurring in the gums next to a tooth root. Tooth abscess leads to pus formation and if left untreated can lead to serious, even life-threatening, complications. The symptoms of a tooth abscess include severe, persistent, throbbing pain in the tooth which can radiate to the jawbone, neck and other associated parts of the head, fever, swelling in cheeks, swollen lymph nodes, sensitivity to hot and cold foods etc. The spread of infection results in foul smell and foul-taste in mouth. The periapical tooth abscess is the most dangerous as bacteria invade the dental pulp which is the innermost part of the tooth that contains blood vessels, nerves and connective tissue.

The market for tooth abscess is driven by factors such as poor dental hygiene due to rise in risk factors such as time constraints due to fast lifestyle, sedentary lifestyles, not brushing your teeth twice a day and lack of flossing etc. Other strong factor is the high sugar diet and junk foods. High sugar diets have high propensity to cause a dental infection whereas junk foods are sticky and retain in the cavities of the teeth for longer times. Drinking sodas can result in slow dissolution of the dental enamel and can lead to rise in cavities due to the weakening of the natural physical barrier of the teeth. The treatment includes draining the abscess followed by antibiotic treatment, performing a root canal etc. Root canal involves the elimination of the infected central tissue, draining the abscess and then filling and sealing the tooth’s pulp chamber with a dental filling material. If the infection is severe and the tooth is damaged beyond recovery, then it has to be extracted out completely to avoid any further complications.

Considering all these factors, the market for dental infection treatment is expected to reach $ 20.5 billion by the end of 2023, this market is projected to growing at a CAGR of ~ 8.6 % during 2017-2023.

Regional analysis

US accounts for the maximum market share due to extensive use of medications and greater expenditure on healthcare. The faster market uptake of new technology and devices in the US is also an important driver of the market for global dental infection treatment. The presence of large device companies in the developed regions is also a major driver of the market. Europe is the second largest market due to large disposable income and rising awareness regarding the health hazards of this condition. Asia Pacific region is expected to have the most future potential and is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The regions of Africa are expected to witness a moderate growth due to poor economic and political conditions and poor healthcare penetration.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Shivkumar is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

Duodenoscopes Market – Industry Growth, Analysis, Size and Share to 2023

Market Research Future adds new report of “Duodenoscopes Market Research Report – Global Forecast till 2023” it contains Company information, geographical data and Table of Content

Duodenoscope is a flexible, lighted weighted tubes that are released through the mouth, throat, and stomach into the top of the small intestine. These are specially designed side viewing endoscope for endoscopic retrograde cholangiopancreatography (ERCP) procedures, which will help to diagnose diseases associated with pancreas and bile ducts with the help of fluoroscopic imaging procedure.

Competitive Analysis:

Some of the key players in this market are FUJIFILM Holdings Corporation, KARL STORZ GmbH & Co. KG, PENTAX Medical, Olympus Corporation, Custom Ultrasonics, Inc., ENDOMED, and SonoScape.

Key Findings

  • The global healthcare BPO market is expected to reach USD 4,815.50 million by 2023 at a CAGR of 6.83%.
  • In flexible duodenoscopes, video duodenoscope is the fastest growing segment, which is projected grow at a CAGR of 7.49% during the forecast period from 2017-2023.
  • Americas hold the largest share of the duodenoscopes market and is expected to reach USD 4,147.66 million by 2023.
  • Asia Pacific is the fastest growing region across the globe and expected to grow at a rate of CAGR 11.01% during the forecast period.

Market Highlight:

Duodenoscope is a more complex device as compared to other endoscopes and is tough to clean and disinfect. These devices play an essential role in the treatment of patients, but there has been some evidences, which showed that some patients were infected with hospital born and other infectious agents, including antibiotic drug-resistant infections due to these devices. In 2013, the Centers for Disease Control and Prevention (CDC) alerted the FDA regarding possible association of multidrug resistant bacterial infections and duodenoscopes. ERCP was associated with infections in 135 patients from January 2013 to December 2014.

The global duodenoscopes market is growing moderately due to increasing prevalence of pancreatic, bile duct cancer tumors, and various gastrointestinal. Additionally, increasing research and development, technological advancements to identify the causes and risk factors associated with transmission of infectious agents from duodenoscopes, and developing new solutions to minimize patient exposure to such infection likely to drive the market growth over the review period.

According to the latest WHO report (World Health Organization), in 2015, 8.8 million people died across the globe from cancer, which is nearly 1 in 6 of all the global deaths. According to the WHO, approximately 70% of deaths from cancer occur in low- and middle-income countries. Moreover, according to a report by the World Gastroenterology Organization, (2014), 35-40% of world’s total population had acute or chronic GI complication.

However, increasing FDA recalls for duodenoscopes due to challenging cleaning and high-level disinfection procedures and rising multidrug-resistant bacterial infections may affect the growth of the global duodenoscopes market negatively.

The global duodenoscopes market is expected to grow at a CAGR of 6.83% during the forecast period 2017-2023.

Market Segmentation:

The global duodenoscopes market is segmented on the basis of types, application, and end user.

On the basis types, it is segmented into rigid duodenoscopes and flexible duodenoscopes. The flexible duodenoscopes is further segmented into fiber-optic duodenoscope and video duodenoscope. On the basis of application, it is segmented into diagnosis and treatment. The diagnosis is further segmented into detect abberations, trauma or surgical complications in bile or pancreatic ducts, tumors or cancers of the bile ducts, inflammation of the pancreas, chronic pancreatitis, pancreatic pseudocysts, and tumors or cancers of the pancreas. The detect abberations is further segmented into bile duct, cystic duct, hepatic ducts, and pancreatic ducts. Treatment is further segmented into cannulation, sphincterotomy, stone management, and drainage of the bile duct. On the basis of end user, it is segmented into gastrologists, general and pediatric surgeons, hospitals, speciality clinics, and others.

Regional Analysis

The Americas dominates the global duodenoscopes market owing to the presence of strong economic condition, huge development in the healthcare domain, and focus of research institutions on updating technology for new and advanced diagnosis and treatment methods. Moreover, advanced hospitals infrastructures, and availability of skilled healthcare professional adding fuel to the growth of the market.

Europe holds the second position in the market on the basis of increasing emphasis on rapid diagnosis and treatment of cancer, and gastrointestinal diseases, changing lifestyle, increasing prevalence of cancer among geriatric population. As per Organization for Economic Co-operation and Development (OECD), Germany spent 11% of the total GDP on healthcare in 2013, which was 10.8% in 2012, which drives the growth of the market in this region.

Asia Pacific is the fastest growing market owing to more number of developing nations present in this region, for instance, countries like India and china. These countries are encouraging the growth of the healthcare domain. Furthermore, increasing patient population from cancer and gastrointestinal diseases in developing countries will directly increase the demand for various diagnosis & treatment methods, which, in turn, will boost the growth of the market.

The Middle East & Africa is expected to hold the least market share due to less availability of medical facilities, and less development in the healthcare domain. However, countries such as Qatar and Kuwait are focusing more on the healthcare domain and developing medical facilities, which will boost the market of this region.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Shivkumar is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

Antihelminthics Market Research Report: Worldwide Analysis 2023

Market Research Future adds new report of “Antihelminthics Market Research Report- Global Forecast till 2023” it contains Company information, geographical data and Table of Content

Antihelminthics are a group of antiparasitic drugs that kill and expel parasitic worms & other internal parasites from the body without causing any significant damage to the patient. These drugs are used for the treatment of various diseases such as fasciolasis, filariasis, angiostrongylosis, and many others. Increasing prevalence of diseases such as schistosomiasis, whipworm infection, ascariasis, and other intestinal infections have boosted the growth of the antihelminthic drugs market.

Competitive Analysis:

Some of key the players in the market are Abbott (US), Novartis AG (Switzerland), ZEISS International (Germany), Johnson & Johnson Services, Inc. (US), Sanofi (US), Merck & Co., Inc. (US), GlaxoSmithKline plc. (US), Astellas Pharma Inc. (Japan), Bayer AG (Germany), Mentis Pharma Ltd. (India), Pfizer Inc. (US), Sanofi (France), ALLERGAN (Ireland), and AstraZeneca (UK)

Market Highlight:

According to the World Health Organization (WHO) in 2014, over 1.5 billion people were infected with soil-transmitted helminthes worldwide. Additionally, a latest report published by the WHO says that more than 880 million children are in the need of treatment for these parasitic diseases. A number of different types of antiparasitic drugs are available in the market for the treatment of the different parasitic diseases. According to a research, ascariasis remains the most common intestinal parasite with 807–1221 million infections globally. It is the most prevalent diseases in East Asia, sub-Saharan Africa, and India. Majority of the patients are in developing region due to unhygienic condition. Over 65% of the patient population suffering from parasitic diseases are present in East Asia, sub-Saharan Africa, and India. Moreover, increasing geriatric population, rapidly developing healthcare sector, and increasing demand for the treatment of the parasitic diseases have fuelled the market growth. On the other hand, the side effects associated with the treatment may slow the market growth over the review period.

The global antihelminthics market is expected to grow at a CAGR of ~5.3 % during the forecast period 2017-2023.

Market Segmentations:

The global antihelminthics market is segmented on the basis of types, application, and end user.

On the basis of types, the market is segmented into benzimidazoles, abamectin, salicylanilides, praziquantel and others. Benzimidazoles is further segmented into albendazole, mebendazole, benzimidazoles, thiabendazole, and others. Salicylanilides is further segmented into niclosamide, oxyclozanide, rafoxanide, and others. On the basis of applications, the market is segmented into schistosomiasis, fasciolasis, filariasis, angiostrongylosis, ascariasis, giardiasis and others. On the basis of end user, the market is segmented into hospitals, clinics, and others. On the basis types, benzimidazoles holds the major share in the market due to their long history and efficiency. A number of different types of benzimidazoles are available in the market, however, certain side effects are observed in the patient, which may slow the growth of the benzimidazoles market.

Regional Analysis

The Americas dominate the global antihelminthics market owing to the increasing prevalence of people with parasitic diseases and presence of huge geriatric population. Additionally, well-developed technology, huge number of patients suffering from autoimmune diseases, and strong government support for research & development will fuel the market growth.

Europe is the second leading market across the globe, which is followed by Asia Pacific. Huge geriatric population, availability of funds for research, and government support for research & development will drive the market. Asia Pacific is the fastest growing antihelminthics market due to the presence of huge patient pool, rapidly growing economy, increasing prevalence of digestive diseases, and presence of huge geriatric population. Some of the regions in the Asia Pacific is still lack the proper hygiene which has led to the growth of the market in this region.

On the other hand, the Middle East & Africa holds the least share of the market owing to limited availability of medical facilities, less availability of funds, and poor political conditions in Africa. Majority of the market of this region is held by Middle East due to a well-developed healthcare sector and huge healthcare expenditure.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Shivkumar is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

Tissue Microarray Market is Increasing Rapidly at CAGR of 13.7% by 2023

marketresearchfuture

Market Research Future adds new report of “Tissue Microarray Market Research Report- Global forecast to 2023” it contains Company information, geographical data and Table of Content

Tissue Microarray is a recent innovation in the field of pathology. A Tissue microarray contains many small representative tissue samples from hundreds of different cases assembled on a single histologic slide, and therefore allows high throughput analysis of multiple specimens at the same time. Tissue microarray s are paraffin blocks produced by extracting cylindrical tissue cores from different paraffin donor blocks and re-embedding these into a single recipient (Tissue microarray ) block at defined array coordinates. Using this technique, up to 1000 or more tissue samples can be arrayed into a single paraffin block. It can permit simultaneous analysis of molecular targets at the DNA, mRNA, and protein levels under identical, standardized conditions on a single glass slide, and also provide maximal preservation and use of limited and irreplaceable archival tissue samples. This versatile technique, in which data analysis is automated, facilitates retrospective and prospective human tissue studies.

Tissue Microarray Global Market – Overview

According to a recent study report published by the Market Research Future, the global market of Tissue Microarray is booming and is analyzed to witness a striking growth in terms of value, with a singular CAGR during the forecasted period (2016 – 2023).

The advent of Tissue microarray in genomics and proteomics is the key market growth propeller. Tissue microarray technology is used for genotyping, mutation screening, protein interaction studies, and gene expression analysis for example DNA Tissue microarray  technology is used to develop new gene expression patterns across gene families, expand gene family size, and discover new categories of genes. Additionally, Tissue microarray technology can also be used to disease diagnosis, which will eventually aid in determining better treatment strategies. Tissue microarray  technology has found extensive applications in the healthcare sector due to its portability, rapid assay times, and fewer sample requirements which has provided an impetus its wide adoption in the future despite of its being an expensive technology.

Tissue Microarray Global Market – Key Players

The global TMA market is adorned as competitive with the presence of many well established players having presence regional and global market.  Large investments are taking place in Tissue microarray market. Innovation, mergers & acquisitions, brand reinforcement and collaboration remain the key trends for leading players.

Some of the key players in this market are: US Biomax Inc., OriGene Technologies Inc., PREMIER Biosoft, Pantomics Inc., Asterand Bioscience, Auria Biopankki, Externautics, Novus Biologicals, LLC, Protein Biotechnologies Inc. and others.

Tissue Microarray Global Market – Segments:

The global TMA Market can be segmented in to 4 key dynamics for the convenience of the report and enhanced understanding;

  • Segmentation on the basis of Types: Comprises – Cell line, Random tissue/tumor, Consecutive case and others.
  • Segmentation on the basis of Applications: Comprises – Immunohistochemistry, FISH, mRNA in situ hybridization, Nucleic acid extraction and others.
  • Segmentation on the basis of End Users : Comprises – Hospitals, Clinics, Diagnostic Centers, Research Laboratories and others.
  • Segmentation on the basis of Regions: Comprises Geographical regions – North America, Europe, APAC and Rest of the World.

Tissue Microarray Global Market – Synopsis

Until recently the research and development of new diagnostic tests in histopathology have always required considerable time, both from technical staff and from pathologists. A large number of specimens have needed to be processed into paraffin blocks, sectioned, stained and assessed microscopically before statistical analysis was possible. In recent years, however, along with the advent of Tissue microarray technologies for genomics and proteomics, histopathology research received a similar much-needed boost by the introduction of tissue microarray technology (TMA).

Tissue microarray technology provides a promising method for the rapid delivery of results in histopathological research. However, in cases where the prognostic significance of findings is important, it remains unreliable because of problems related to the heterogeneity of antigen expression. In such cases, conventional histology must remain the gold standard for the foreseeable future. It is probable that with the falling costs of technology, and increased competition between developers, TMA will become an easily affordable, justifiable and commonly used tool for archiving rare or scarce material and for inter-laboratory quality assurance procedures in routine histopathology laboratories. This may lead to more research work being carried out in smaller centers

Tissue Microarray Market – Regional Analysis

Globally North America is the largest market for Tissue microarray. The North American market for Tissue microarray is expected to grow at a substantial CAGR and is expected to reach at astronomical amounts by the end of the forecasted period. North America is expected to continue its dominance until nearing future due to an increase in research investments made by several biotechnology and pharmaceutical companies to develop targeted therapeutics using Tissue microarray technologies.

Asia and Europe are equally the second-largest market for Tissue microarray which is expected to grow at a considerable CAGR during 2016 – 2023.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Shivkumar is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

Drug Allergy Industry: Global Survey, Trends, Outlook, Forecast by 2023

marketresearchfuture

Market Research Future adds new report of “Drug Allergy Market Research Report – Global forecast till 2023” it contains Company information, geographical data and Table of Content

Drug allergy is one of the most common types of allergies. It is the hyper sensitivity of the immune system to drug or medication. Any types of drugs such as prescription, nonprescription or herbal can induce drug allergy. Some common symptoms of the drug allergies are hives, skin rash, itching of the eyes or skin, swelling of the face, lips, or tongue, wheezing, and others. Treatment can relieve and prevent severe reactions.

Competitive Analysis:

Some of the key players in this market: AstraZeneca (UK), Bayer (US), Circassia (US), HAL Allergy Group (the Netherlands), Johnson & Johnson Services, Inc. (US), MAGNA Pharmaceuticals, Inc. (US), Stallergenes Greer (UK), and others.

Market Segments:

The global drug allergy market is segmented on the basis of type, which comprises of immunologic, nonimmunologic, and others. Immunologic allergy is sub-segmented into type I reaction, type II reaction, type III reaction, type IV reaction, and others. The non-immunologic allergy is sub-segmented into predictable, unpredictable, and others. The predictable allergy is further segmented into pharmacologic side effect, secondary pharmacologic side effect, drug toxicity, drug-drug interactions, drug overdose, and others. The unpredictable segment is further sub-segmented into pseudoallergic, idiosyncratic, intolerance, and others. On the basis of diagnosis, the market is segmented into skin tests, blood tests, patch test, and others. The skin test is further segmented into prick or scratch test, intradermal test, and others. On the basis of treatments, the market is segmented into antihistamines, corticosteroids, treatment of anaphylaxis, withdrawal of the drug, and others. Antihistamines are further sub-segmented into azelastine eyedrops, azelastine nasal sprays, carbinoxamine, cyproheptadine, desloratadine, diphenhydramine, emedastine eyedrops, hydroxyzine, levocabastine eyedrops, levocabastine oral, and others. Corticosteroids is further sub-segmented into topical steroids, inhaled steroids, and others. Inhaled steroids is further segmented into flunisolide, fluticasone furoate, fluticasone propionate, triamcinolone acetonide, beclomethasone dipropionate, budesonide, and others. On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.

Market Highlight:

Increasing awareness about various allergies, the introduction of the new treatment of products and rising demand from emerging markets drives the growth of the global market. New research to prevent drug allergies is another key driver for the market. The global drug allergy market is growing moderately and is expected to continue its growth over the forecast period.

The global drug allergy market is expected to grow at the CAGR of ~5.1% during the forecast period and is estimated to reach USD 4764.0 million by 2023.

Regional Analysis of the Global Drug Allergy Market    

The Americas dominate the global market for the drug allergy. The Americas mainly include North America and Latin America, out of which North America accounts for the majority of the market share of this region. The US is the top revenue generating market in North America and is one of the important markets for the global drug allergy treatment. Approximately 10% of the total US population have drug allergies. Latin America drug allergy market is also growing significantly and mainly includes Brazil, Argentina, and Chile. Europe is the second largest market in the globe owing to increasing cases of drug allergy.

Europe is mainly divided into Eastern Europe and Western Europe. More developed Western European countries like Germany, UK and France are dominating this market while East European region is also growing significantly. Increasing cases of drug allergies are one of the major factors for the growth of the Europe market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Shivkumar is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

Artificial Pancreas Market to Rise at CAGR of 15.2% by 2023

marketresearchfuture

Market Research Future adds new report of “Artificial Pancreas Market Research Report- Global Forecast till 2023” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Key players profiled in the report are

  • Medtronic
  • Johnson & Johnson
  • Beta Bionics
  • Bigfoot Biomedical
  • Admetsys (pipeline product analysis)
  • Animas Corporation
  • Defymed
  • dexcom
  • Insulet
  • medtech
  • Semma Therapeutics
  • Tandem Diabetes Care
  • TypeZero Technologies

Market Segments:

The global artificial pancreas market is segmented on the basis of type and end users.

  • Based on Type, the market has been segmented as threshold suspend device system, non-threshold suspend device system, control-to-range (CTR) system, and control-to-target (CTT) system
  • Based on the Treatment Type, the market has been segmented as insulin only, bi-hormonal, and hybrid. Based on the end users, the market has been segmented as hospitals and clinics, research

Market Highlight:

Artificial pancreas are devices that mimics the glucose regulating function of healthy pancreas. These devices use computer-controlled algorithm so as to precisely calculate the amount of insulin to be delivered by using an insulin infusion pump. Advanced products can deliver bi-hormones so as to avoid excessive fall in blood sugar and more closely mimic the working of healthy pancreas with little or no input from the patient.

Considering all these factors the market for Artificial Pancreas is expected to reach $ 360 million by the end of 2023, this market is projected to growing at a CAGR of ~ 15.2 % during 2017-2023.

Study objectives:

  • To provide a detailed analysis of the market structure along with estimated future growth forecast for the next six years about various segments and sub-segments of the global Artificial Pancreas market.
  • To provide insights about factors affecting the market growth.
  • To analyze the global Artificial Pancreas market based on various factors – Price Analysis, Supply Chain Analysis, Porters Five Force analysis etc.
  • To provide country level analysis of the market with respect to the current market size and future growth prospects.
  • To provide country level analysis of the market which includes segmentation by type, treatment type and end users.

Intended Audience

  • Global Artificial Pancreas, manufacturers & suppliers
  • Research and development (R&D) companies
  • Market research and consulting service providers
  • Academic institutes and universities

Regional analysis

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global artificial pancreas. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is expected to have the most potential which is estimated to be led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions and poor healthcare penetration.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Shivkumar is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

Diphtheria Treatment Market is expected to Rise at a Remarkable CAGR of 3.2% by 2027

marketresearchfuture

Market Research Future adds new report of “Diphtheria Treatment Market Research Report- Global Forecast till 2023” it contains Company information, geographical data and Table of Content

Competitive Analysis:

Key players profiled in the report are

  • Taj Pharmaceuticals Limited
  • Bharat Pharmaceuticals
  • GSK
  • Sanofi-Pasteur
  • Merck & Co.
  • Shanghai Institute of Biological Products
  • Wuhan Institute of Biological Products
  • Serum Institute of India
  • Wyeth
  • Chiron Pharmaceutical Pvt. Ltd.

Market Segments:

The global diphtheria treatment market is segmented on the basis of product type and end users.

  • Based on Product Type, the market has been segmented as Tetanus Immune Globulin (TIG), Tetanus Toxoid (TT), Tetanus-diphtheria (Td), Diphtheria Toxoid and Pertussis (DTaP)
  • Based on the Treatment, the market has been segmented as antitoxin, antibiotics, macrolides
  • Based on the End Users, the market has been segmented as hospitals and clinics, academics and research

Market Highlight:

Diphtheria is an infectious disease caused by the bacterium Corynebacterium diphtheria causing severe sore throat and fever leading to narrowing of the air passages and barking cough. Diphtheria may also affect the skin, eyes, or genitals and may cause myocarditis, bleeding and kidney problems.

The global diphtheria treatment market is growing at a slow rate due to high effectiveness and efficiency of the vaccine, falling profitability of vaccine manufacture, side effects associated with vaccines such as type A immune reaction and allergies, variability in the efficacy of vaccines. Financial restraints such as falling returns on investment and the resultant exit of a number of players from vaccine manufacture will affect the future growth of vaccines.

Considering all these factors the market for diphtheria treatment is expected to reach $ 5 billion by the end of 2023, this market is projected to be growing at a CAGR of ~ 3.2 % during 2017-2023.

Study objectives:

  • To provide a detailed analysis of the market structure along with estimated future growth forecast for the next six years about various segments and sub-segments of the global diphtheria treatment market.
  • To provide insights about factors affecting the market growth.
  • To analyze the global diphtheria treatment market based on various factors – Price Analysis, Supply Chain analysis, Porters Five Force analysis etc.
  • To provide country level analysis of the market with respect to the current market size and future growth prospects.
  • To provide country level analysis of the market which includes segmentation by product type, treatment and end users.

Intended Audience

  • Global diphtheria treatment, manufacturers & suppliers
  • Research and development (R&D) companies
  • Market research and consulting service providers
  • Academic institutes and universities

Regional analysis

US accounts for the maximum market share due to favorable reimbursement scenario and greater expenditure on healthcare. The faster market uptake of new technology in the US is also an important driver of the market for global diphtheria treatment. Europe is the second largest market due to large disposable income and rising awareness. Asia Pacific region is the fastest region because of large unmet needs which is led by China and India. The Middle East & Africa market is led by the gulf nations particularly Saudi Arabia and UAE. The poor regions of Africa are expected to be a laggard due to poor economic and political conditions and poor healthcare penetration. Asia Pacific region is expected to overtake the developed regions in the near future.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

 

Shivkumar is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

Drug Allergy Industry: Future Demand, Market Analysis & Outlook to 2023

marketresearchfuture

Market Research Future adds new report of “Drug Allergy Market Research Report – Global forecast till 2023” it contains Company information, geographical data and Table of Content

Drug allergy is one of the most common types of allergies. It is the hyper sensitivity of the immune system to drug or medication. Any types of drugs such as prescription, nonprescription or herbal can induce drug allergy. Some common symptoms of the drug allergies are hives, skin rash, itching of the eyes or skin, swelling of the face, lips, or tongue, wheezing, and others. Treatment can relieve and prevent severe reactions.

Competitive Analysis:

Some of the key players in this market: AstraZeneca (UK), Bayer (US), Circassia (US), HAL Allergy Group (the Netherlands), Johnson & Johnson Services, Inc. (US), MAGNA Pharmaceuticals, Inc. (US), Stallergenes Greer (UK), and others.

Market Segments:

The global drug allergy market is segmented on the basis of type, which comprises of immunologic, nonimmunologic, and others. Immunologic allergy is sub-segmented into type I reaction, type II reaction, type III reaction, type IV reaction, and others. The non-immunologic allergy is sub-segmented into predictable, unpredictable, and others. The predictable allergy is further segmented into pharmacologic side effect, secondary pharmacologic side effect, drug toxicity, drug-drug interactions, drug overdose, and others. The unpredictable segment is further sub-segmented into pseudoallergic, idiosyncratic, intolerance, and others. On the basis of diagnosis, the market is segmented into skin tests, blood tests, patch test, and others. The skin test is further segmented into prick or scratch test, intradermal test, and others. On the basis of treatments, the market is segmented into antihistamines, corticosteroids, treatment of anaphylaxis, withdrawal of the drug, and others. Antihistamines are further sub-segmented into azelastine eyedrops, azelastine nasal sprays, carbinoxamine, cyproheptadine, desloratadine, diphenhydramine, emedastine eyedrops, hydroxyzine, levocabastine eyedrops, levocabastine oral, and others. Corticosteroids is further sub-segmented into topical steroids, inhaled steroids, and others. Inhaled steroids is further segmented into flunisolide, fluticasone furoate, fluticasone propionate, triamcinolone acetonide, beclomethasone dipropionate, budesonide, and others. On the basis of end user, it is segmented into hospitals & clinics, medical research centers, academic institutes, and others.

Market Highlight:

Increasing awareness about various allergies, the introduction of the new treatment of products and rising demand from emerging markets drives the growth of the global market. New research to prevent drug allergies is another key driver for the market. The global drug allergy market is growing moderately and is expected to continue its growth over the forecast period.

The global drug allergy market is expected to grow at the CAGR of ~5.1% during the forecast period and is estimated to reach USD 4764.0 million by 2023.

Regional Analysis of the Global Drug Allergy Market    

The Americas dominate the global market for the drug allergy. The Americas mainly include North America and Latin America, out of which North America accounts for the majority of the market share of this region. The US is the top revenue generating market in North America and is one of the important markets for the global drug allergy treatment. Approximately 10% of the total US population have drug allergies. Latin America drug allergy market is also growing significantly and mainly includes Brazil, Argentina, and Chile. Europe is the second largest market in the globe owing to increasing cases of drug allergy.

Europe is mainly divided into Eastern Europe and Western Europe. More developed Western European countries like Germany, UK and France are dominating this market while East European region is also growing significantly. Increasing cases of drug allergies are one of the major factors for the growth of the Europe market.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Shivkumar is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO

Tissue Microarray Market Overview, Analysis and Forecasts to 2023

marketresearchfuture

Market Research Future adds new report of “Tissue Microarray Market Research Report- Global forecast to 2023” it contains Company information, geographical data and Table of Content

Competitive Analysis:

  • Abcam plc. (U.K)
  • Externautics (Italy)
  • Asterand Bioscience (U.S)
  • Auria Biopankki (Finland)
  • US Biomax Inc. (U.S)
  • Protein Biotechnologies Inc. (U.S)
  • OriGene Technologies Inc. (U.S)
  • Novus Biologicals LLC (U.S)

Market Segmentation:

Global Tissue microarray market has been segmented

  • On the basis of Type of Tissue Microarray which includes cell line, frozen tissue array, paraffin embedded tissue array
  • On the basis of Application the market is segmented into immunohistochemistry, FISH, mRNA in situ hybridization, nucleic acid extraction
  • On the basis of End Users are hospitals, clinics, diagnostic centers, research laboratories

Market Highlight:

Tissue microarray enables thorough analysis of multiple tissues or cell samples. Large amount of data is generated automatically providing reliable results. Results for large number of samples can be obtained within seconds at the same time. Another advantage of tissue microarray is that only small amount of tissue sample is needed. It is used in global analysis of protein expression in normal human tissues, cancer and cell lines within Human Protein Atlas (HPA). These advantages favor the growth of tissue microarray market. Wide application of tissue microarray in pathology also drive this market. Increasing application of tissue microarray in drug discovery and oncology, automated analysis of results and influence of technology drive this market. Drawback of tissue microarray is that it may not be fruitful for heterogeneous cancers and the sample may not represent the entire tumor. Global market of tissue microarray is expected to reach USD 340 billion in 2023 from USD 220 billion in 2016 with a CAGR of approximately 13.7% during the forecast period 2017-2023.

Study objectives:

Main objective of this research is to provide information about Tissue microarray market, type of tissue microarray, application and end-users.

  • To provide detailed analysis of the market structure along with forecast for the next seven years of the various segments and sub-segments of the tissue microarray market.
  • To provide insights about factors affecting the market growth.
  • To analyze the tissue microarray market based on various factors- price analysis, supply chain analysis, porters five force analysis etc.
  • To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, Asia-Pacific and Middle East and Africa.
  • To provide country level analysis of the market with respect to the current market size and future prospective.
  • To provide country level analysis of the market for segments by type, by application, by end users and its sub-segments.

Intended Audience

  • Medical device manufacturers
  • Medical device suppliers
  • Contract Research Organizations (CROs)
  • Research and Development (R&D) Companies
  • Academic Medical Institutes and Universities

Regional Analysis:

Globally, tissue microarray market consists of four regions Americas, Europe, Asia-Pacific and Middle East and Africa. America is the largest market. Increase in technology adoption, rising incidence of cancer and increasing healthcare expenditure drive this market in America. Europe is the second largest market. Asia Pacific shows steady growth in this market. The market shows slow growth in Middle East and Africa.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

Contact:

Akash Anand,

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: akash.anand@marketresearchfuture.com

Shivkumar is a Digital Marketer by professional and he has a great experience in blogging, content writing and SEO